US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Cefepime

Reason Lack of sterility assurance

Sentara Infusion Services D-0280-2023
Class II · Moderate risk Terminated

Cefazolin

Reason Lack of sterility assurance

Sentara Infusion Services D-0278-2023
Class II · Moderate risk Terminated

Caspofungin 50mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0277-2023
Class II · Moderate risk Terminated

Ampicillin 8gm in Ns 400ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0275-2023
Class II · Moderate risk Terminated

Ampicillin 12gm in Ns 600m

Reason Lack of sterility assurance

Sentara Infusion Services D-0274-2023
Class II · Moderate risk Terminated

Amikacin 450MG IN NS 45ML

Reason Lack of sterility assurance

Sentara Infusion Services D-0273-2023
Class II · Moderate risk Terminated

0.9% Sodium Chloride

Reason Lack of sterility assurance

Sentara Infusion Services D-0272-2023
Class II · Moderate risk Terminated

Voriconazole 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0243-2023
Class II · Moderate risk Terminated

Vitamin D3-Aqueous- 10

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0242-2023
Class II · Moderate risk Terminated

Vancomycin Fortified 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0241-2023
Class II · Moderate risk Terminated

Tobramycin Fortified 15mg/Ml Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0240-2023
Class II · Moderate risk Terminated

Testosterone 3%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0238-2023
Class II · Moderate risk Terminated

Tacrolimus 0.03% Oph Solution Tacrolimus 0.1%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0237-2023
Class II · Moderate risk Terminated

Semaglutide 0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0236-2023
Class II · Moderate risk Terminated

Scopolamine Hydrobromide 0.25% Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0235-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0234-2023
Class II · Moderate risk Terminated

Progesterone-Gs Oil- 100mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0233-2023
Class II · Moderate risk Terminated

Polyhexamethylene Biguanide 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0232-2023
Class II · Moderate risk Terminated

Polidocanol 50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0231-2023
Class II · Moderate risk Terminated

Phosphatidylcholine/Deoxycholic Acid

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0230-2023
Class II · Moderate risk Terminated

Phenol 10%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0229-2023
Class II · Moderate risk Terminated

Pe1/Papav/Phen 20mcg/30mg/2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0228-2023